Lisa Cosgrove

Lightning Rounds I - Ending Institutional Corruption

"Implementation of Blinded Expert Review in Radiology Malpractice Litigation"
Jeffrey Robinson, Assistant Professor of Radiology, University of Washington; President, Cleareview

"Psychiatry Under the Influence: Institutional Corruption, Social Injury, and Prescriptions for Reform"
Robert Whitaker, freelance journalist
Lisa Cosgrove, Clinical Psychologist and Professor, University of Massachusetts, Boston

"Rootstriking Pharmaceutical Corruption of Research, Medical Knowledge, and Practice"
Donald Light...

Read more about Lightning Rounds I - Ending Institutional Corruption

Lisa Cosgrove and Robert Whitaker — Psychiatry Under the Influence: A Case Study of Institutional Corruption

The April 17, 2013 Lab seminar was led by Professor Lisa Cosgrove and Mr. Robert Whitaker, who are both Edmond J. Safra Center Fellows. During this fellowship year they have been collaborating on a project addressing ethical and medico-legal issues that arise in psychiatry because of financial conflicts of interest. Professor Cosgrove began the...

Read more about Lisa Cosgrove and Robert Whitaker — Psychiatry Under the Influence: A Case Study of Institutional Corruption

WP 09. May 9, 2013

Lisa Cosgrove and Robert Whitaker, Finding Solutions to Institutional Corruption: Lessons from Cognitive Dissonance Theory

Lisa Cosgrove — Re-Thinking the Meaning of Evidence-Based Psychiatry in an Age of Big Pharma

The December 1, 2010, seminar was presented by Lisa Cosgrove, Edmond J. Safra Lab Fellow and Associate Professor in the Department of Counseling and School Psychology at University of Massachusetts, Boston. Lisa's research deals with institutional corruption in the field of psychiatry. This is a particularly vulnerable area because, unlike most other fields in medicine, there are no biological markers, leaving more room for interpretation and abuse. Lisa's presentation explored the ways that industry influence may distort...

Read more about Lisa Cosgrove — Re-Thinking the Meaning of Evidence-Based Psychiatry in an Age of Big Pharma